Correlation Between Bristol-Myers Squibb and Roche Holding

Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Roche Holding Ltd, you can compare the effects of market volatilities on Bristol-Myers Squibb and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Roche Holding.

Diversification Opportunities for Bristol-Myers Squibb and Roche Holding

0.59

Correlation Coefficient

Bristol-Myers Squibb  Roche Holding

Very weak diversification

The 3 months correlation between Bristol-Myers and Roche is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Roche Holding go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Roche Holding

Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Roche Holding. In addition to that, Bristol-Myers Squibb is 2.66 times more volatile than Roche Holding Ltd. It trades about -0.13 of its total potential returns per unit of risk. Roche Holding Ltd is currently generating about 0.31 per unit of volatility. If you would invest  3,932  in Roche Holding Ltd on December 5, 2024 and sell it today you would earn a total of  320.00  from holding Roche Holding Ltd or generate 8.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	85.71%
Values	Daily Returns

Bristol Myers Squibb  vs.  Roche Holding Ltd

Bristol Myers Squibb

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Roche Holding

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding Ltd are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Roche Holding showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol-Myers Squibb and Roche Holding

The main advantage of trading using opposite Bristol-Myers Squibb and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.

The idea behind Bristol Myers Squibb and Roche Holding Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.